Calcium Channel Blocker versus Angiotensin II Receptor Blocker in Autosomal Dominant Polycystic Kidney Disease-Reference-Cited by-同舟云学术

Calcium Channel Blocker versus Angiotensin II Receptor Blocker in Autosomal Dominant Polycystic Kidney Disease

Published:2005-01-14 Issue:1 Volume:99 Page:c18-c23
ISSN:1660-2110
Container-title:Nephron Clinical Practice
language:en
Short-container-title:Nephron Clin Pract

Author:

Nutahara Kikuo,Higashihara Eiji,Horie Shigeo,Kamura Kouichi,Tsuchiya Ken,Mochizuki Toshio,Hosoya Tatsuo,Nakayama Tomohiro,Yamamoto Norio,Higaki Yoshio,Shimizu Toshiko

Publisher

S. Karger AG

Subject

Nephrology,General Medicine

Reference19 articles.

1. The pathogenesis of hypertension in autosomal dominant polycystic kidney disease

2. Watoson ML: Hypertension in polycystic disease; in Watson ML, Torres VE (eds): Polycystic Kidney Disease. Oxford, Oxford University Press, 1996, pp 407-429.

3. Prevalence and Renal Prognosis of Diagnosed Autosomal Dominant Polycystic Kidney Disease in Japan

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Experience of a Reference Center on Autosomal Dominant Polycystic Kidney Disease: Associated Demographics, Clinical Presentation, and Kidney Survival in Turkish Population;Turkish Journal of Nephrology;2023-10-02

2. Management of Hypertension and Associated Cardiovascular Disease in Autosomal Dominant Polycystic Kidney Disease;Advances in Kidney Disease and Health;2023-09

3. Hydrogen Sulfide as a Potential Future Therapy for Chronic Kidney Disease, Hyperhomocysteinemia, and Management of Polycystic Kidney Disease;Hydrogen Sulfide in Kidney Diseases;2023

4. Angiotensin II and polycystic kidney disease;Angiotensin;2023

5. A Systematic Review of Reported Outcomes in ADPKD Studies;Kidney International Reports;2022-09